Table 1 Baseline characteristics of patients with primary biliary cholangitis. Baseline characteristics of 30 patients with primary biliary cholangitis including gender, age at baseline, time since diagnosis, laboratory parameters (ALP, GGT, ALT, AST and TBIL), stage of PBC (at time of diagnosis, according to histology), symptoms of PBC and drug dose per body weight (mg/kg/d)
Baseline characteristics | Total (n = 30) | |
|---|---|---|
Gender | ||
Female | n (%) | 28 (93.33) |
Male | n (%) | 2 (6.67) |
Age at baseline (years) | Mean ± SD | 56.73 ± 11.48 |
Time since diagnosis, (years) | Mean ± SD | 10.77 ± 5.26 |
Laboratory parameters | ||
ALP (U/L) | Mean ± SD | 126.10 ± 91.13 |
GGT (U/L) | Mean ± SD | 105.73 ± 118.22 |
ALT (U/L) | Mean ± SD | 35.78 ± 26.54 |
AST (U/L) | Mean ± SD | 33.92 ± 18.10 |
TBIL (mg/dL) | Mean ± SD | 0.59 ± 0.31 |
Stage of PBC (at time of diagnosis, according to histology) | ||
Stage I | n (%) | 4 (13.33) |
Stage II | n (%) | 4 (13.33) |
Stage III or IV | n (%) | 5 (16.67) |
Unknown stage | n (%) | 11 (36.67) |
No histology | n (%) | 6 (20) |
Symptoms of PBC | ||
Pruritus | n (%) | 18 (60) |
Asymptomatic | n (%) | 7 (23.33) |
Pruritus and fatigue | n (%) | 5 (16.67) |
Drug dose per body weight (mg/kg/d) | Mean ± SD | 13.89 ± 1.76 |